Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
Publikation: Beitrag in Fachzeitschrift › Kommentar (Comment) / Leserbriefe ohne eigene Daten › Beigetragen › Begutachtung
Beitragende
Abstract
The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.
Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 2169-2173 |
Seitenumfang | 5 |
Fachzeitschrift | Blood |
Jahrgang | 144 |
Ausgabenummer | 21 |
Publikationsstatus | Veröffentlicht - 21 Nov. 2024 |
Peer-Review-Status | Ja |
Externe IDs
Scopus | 85203490901 |
---|
Schlagworte
Schlagwörter
- Humans, Leukemia, Myeloid, Acute/genetics, Adult, Risk Assessment, Genetic Predisposition to Disease, Risk Factors